Cost-effectiveness of "full spectrum endoscopy" colonoscopy for colorectal cancer screening

Digestive and Liver Disease

Volumn 47, Issue 5, 2015, Pages 390-394

  Hassan, Cesare ^a   Gralnek, Ian M ^b  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Colonoscopy; Colorectal cancer screening; Cost effectiveness; Endoscopist; Full spectrum endoscopy; Interval cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; FULL SPECTRUM ENDOSCOPY; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; POLYPECTOMY; PRIORITY JOURNAL; VERY ELDERLY; COHORT ANALYSIS; COLORECTAL NEOPLASMS; COST BENEFIT ANALYSIS; EARLY DIAGNOSIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROBABILITY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; MIDDLE AGED;

EID: 84928823773     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.01.154     Document Type: Article

References (41)

1. Edwards B.K., Ward E., Kohler B.A., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010, 116:544-573.
2. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology 2007, 18:581-592.
3. Zauber A.G., Winawer S.J., O'Brien M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. New England Journal of Medicine 2012, 366:687-696.
4. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. American Journal of Gastroenterology 2009, 104:739-750.
5. Lieberman D.A., Rex D.K., Winawer S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastroenterology 2012, 143:844-857.
6. Kaminski M.F., Regula J., Kraszewska E., et al. Quality indicators for colonoscopy and the risk of interval cancer. New England Journal of Medicine 2010, 362:1795-1803.
7. Corley D.A., Jensen C.D., Marks A.R., et al. Adenoma detection rate and risk of colorectal cancer and death. New England Journal of Medicine 2014, 370:1298-1306.
8. Rogal S.S., Pinsky P.F., Schoen R.E. Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clinical Gastroenterology and Hepatology 2013, 11:73-78.
9. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. American Journal of Gastroenterology 2006, 101:343-350.
10. Gralnek I.M., Carr-Locke D.L., Segol O., et al. Comparison of standard forward-viewing mode versus ultra wide-viewing mode of a novel colonoscopy platform: a prospective, multicenter study in the detection of simulated polyps in an in vitro colon model (with video). Gastrointestinal Endoscopy 2013, 77:472-479.
11. Gralnek I.M., Segol O., Suissa A., et al. A prospective cohort study evaluating a novel colonoscopy platform featuring full-spectrum endoscopy. Endoscopy 2013, 45:697-702.
12. Gralnek I.M., Siersema P.D., Halpern Z., et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncology 2014, 15:353-360.
13. DiSario J.A., Foutch P.G., Mai H.D., et al. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. American Journal of Gastroenterology 1991, 86:941-945.
14. Vatn M.H., Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982, 49:819-825.
15. Rickert R.R., Auerbach O., Garfinkel L., et al. Adenomatous lesions of the large bowel: an autopsy survey. Cancer 1979, 43:1847-1857.
16. Arminski T.C., McLean D.W. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Diseases of the Colon and Rectum 1964, 7:249-261.
17. Stemmermann G.N., Heilbrun L.K., Nomura A., et al. Adenomatous polyps and atherosclerosis: an autopsy study of Japanese men in Hawaii. International Journal of Cancer 1986, 38:789-794.
18. Eide T.J. The age-, sex-, and site-specific occurrence of adenomas and carcinomas of the large intestine within a defined population. Scandinavian Journal of Gastroenterology 1986, 21:1083-1088.
19. Johnson D.A., Gurney M.S., Volpe R.J., et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. American Journal of Gastroenterology 1990, 85:969-974.
20. Yee J., Akerkar G.A., Hung R.K., et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology 2001, 219:685-692.
21. Williams A.R., Balasooriya B.A., Day D.W. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982, 23:835-842.
22. Clark J.C., Collan Y., Eide T.J., et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer. International Journal of Cancer 1985, 36:179-186.
23. Anonymous. [accessed at on 15.01.13]. http://www.cdc.gov/.
24. Chen C.D., Yen M.F., Wang W.M., et al. A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. British Journal of Cancer 2003, 88:1866-1873.
25. Church J.M. Clinical significance of small colorectal polyps. Diseases of the Colon and Rectum 2004, 47:481-485.
26. Butterly L.F., Chase M.P., Pohl H., et al. Prevalence of clinically important histology in small adenomas. Clinical Gastroenterology and Hepatology 2006, 4:343-348.
27. Anonymous. National Center for Health Statistics. National Vital Statistics Report. http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_09pdf.
28. Lieberman D.A., Rex D.K., Winawer S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143:844-857.
29. Hassan C., Quintero E., Dumonceau J.M., et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2013, 45:842-851.
30. Rex D.K., Overhiser A.J., Chen S.C., et al. Estimation of impact of American College of Radiology recommendations on CT colonography reporting for resection of high-risk adenoma findings. American Journal of Gastroenterology 2009, 104:149-153.
31. Hassan C., Rex D.K., Cooper G.S., et al. Endoscopist-directed propofol administration versus anesthesiologist assistance for colorectal cancer screening: a cost-effectiveness analysis. Endoscopy 2012, 44:456-464.
32. Hassan C., Pickhardt P.J., Rex D.K. A resect and discard strategy would improve cost-effectiveness of colorectal cancer screening. Clinical Gastroenterology and Hepatology 2010, 8:865-869. 869.e1-3.
33. Hassan C., Pickhardt P.J., Laghi A., et al. Impact of whole-body CT screening on the cost-effectiveness of CT colonography. Radiology 2009, 251:156-165.
34. Anonymous. [accessed at on 15.09.12]. http://www.cms.hhs.gov/.
35. Anonymous. U.S. Department of Labor. Bureau of Labor Statistics. Consumer price index for all urban consumers (CPI-U), U.S. city average, medical care. Available at: [accessed 14.02.13]. http://www.blsgov/cpi/home.htm.
36. National Compensation Survey: Occupational Earnings in the United States, 2010. http://www.bls.gov/.
37. Pignone M., Saha S., Hoerger T., et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2002, 137:96-104.
38. Tengs T.O., Wallace A. One thousand health-related quality-of-life estimates. Medical Care 2000, 38:583-637.
39. Lansdorp-Vogelaar I., Knudsen A.B., Brenner H. Cost-effectiveness of colorectal cancer screening - an overview. Best Practice and Research Clinical Gastroenterology 2010, 24:439-449.
40. Joseph D.A., King J.B., Miller J.W., et al. Prevalence of colorectal cancer screening among adults - Behavioral Risk Factor Surveillance System, United States, 2010. Morbidity and Mortality Weekly Report 2012, 61(Suppl.):51-56.
41. International Data Base. US Census Bureau. Available from: [accessed 05.06.14]. http://www.census.gov/ipc/www/idbnew.html.